Skip to main content
. 2019 Sep 5;19:879. doi: 10.1186/s12885-019-6115-1

Table 2.

Presence of bft gene in CRC patients with respect to disease status

Stage of cancer Stage I Stage II Stage III P value
bft gene (n = 11) (n = 26) (n = 23)
bft positive (n = 19) 2 (18.2%) 5 (19.2%) 12 (52.2%) 0.027
bft negative (n = 41) 9 (81.8%) 21 (80.8%) 11 (47.8%)